Seeking Alpha: Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress
Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress
Get the official YouTube app on Android phones and tablets. See what the world is watching -- from the hottest music videos to what’s popular in gaming, fashion, beauty, news, learning and more....
Get the official YouTube app on iPhones and iPads. See what the world is watching -- from the hottest music videos to what’s popular in gaming, fashion, beauty, news, learning and more.
Upstream Bio, Inc. ( (UPB)) has released its Q3 earnings. Here is a breakdown of the information Upstream Bio, Inc. presented to its investors. Upstream Bio, Inc. is a clinical-stage biotechnology ...
MSN: Upstream Bio lead drug pivotal trial plan follows strong phase 2 data
Upstream Bio Inc. UPB shares are up on Thursday following the company’s announcement of a Phase 3 development strategy for its treatment, verekitug. The company reported a cash position of $341.5 ...
Upstream Bio lead drug pivotal trial plan follows strong phase 2 data
Nasdaq: Upstream Bio, Inc. Completes Enrollment in Phase 2 Trial of Verekitug for Chronic Rhinosinusitis and Raises $293 Million in IPO
Upstream Bio completed Phase 2 trial enrollment for verekitug and raised $293 million in an IPO, funding operations through 2027. Upstream Bio, Inc. announced the completion of patient enrollment in ...
Upstream Bio, Inc. Completes Enrollment in Phase 2 Trial of Verekitug for Chronic Rhinosinusitis and Raises $293 Million in IPO